Volunteering curbs: drug industry aims to avoid price limits through self-control

Article Abstract:

The pharmaceutical industry is offering to impose voluntary price controls to try to stave off government-mandated limits. In return, the industry is hoping for relief from antitrust regulation. Clinton and key Congressional leaders have expressed skepticism at the industry's ability to police itself. Drug company executives warn that cutting drug prices will inhibit the industry's ability to research and develop new drugs, but government figures show that most drug companies make large profits, even after research costs are deducted. US drug company revenues totaled $50 billion for FY 1992.

Drugs, Finance, Prices and rates

---

Carving up a smaller GME pie; House debates allocation of limited residency slots

Article Abstract:

The American Medical Association's House of Delegates debated at its 1996 annual meeting the future of graduate medical education. Medical education faces great changes because of upheavals in the health care delivery system, a predicted physician glut, and reductions in residency slots. The Medical Student Section favored a proposal that would give priority to U.S. medical school graduates in domestic residency slot allocations. International medical students strongly opposed the measure, instead favoring allocation solely on the basis of merit.

Management, Social policy, Graduate medical education, American Medical Association. House of Delegates

---

Pitched battle for patch patients; companies vie for market share with stop-smoking products

Article Abstract:

Patent infringement suits have been dismissed, so pharmaceutical companies can compete to market nicotine patches, to help smokers break the habit. First on the multi-million dollar market was Marion Merrell Dow Inc's Nicoderm, followed by Ciba-Geigy Corp's Habitrol and Lederle Laboratories Div's ProStep. Warner-Lambert Co's product has not yet been cleared by the Food and Drug Administration. The companies' extensive advertising includes educational booklets, hot lines, and rebates toward repeat programs in case of relapse.

Drug therapy, Market share, Smoking cessation programs, Smoking cessation

Similar abstracts:

• Abstracts: The politics of local tobacco control. New tobacco industry strategy to prevent local tobacco control. Removing the incentive to sell kids tobacco: a proposal
• Abstracts: Shooting the learning curve: laparoscopic surgery problems trigger moves for better control of new procedures
• Abstracts: Shooting the learning curve: laparoscopic surgery problems trigger moves for better control of new procedures. part 2
• Abstracts: Communication with deaf patients: knowledge, beliefs, and practices of physicians. Violence, values, and gender
• Abstracts: Reformers willing, critics wary on alternative tort system. The man who would save the system

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.